SUREAdvisorShares Insider Advantage ETF
Seeks to generate long-term capital appreciation.
By AdvisorShares · Launched 2011
Annual Cost
0.90%
#4,535 of 5,562 · expensive
Fund Size
$54M
#3,514 of 5,562 · mid-size
Return (1Y)Goal
+25.4%
Track Record
14 years
#930 of 5,562 · established
Performance
Total-return NAV · USDGrowth of $10,000
$12,470+24.7%
Total-return NAV, USD. Net of fund fees, before tax.
Classification
How Beacon categorizes this fundWhat it actually holds
By weightConcentration
Top 10 holdings = 10.2% of fund✓ well diversified
Exxon Mobil Corp
1.0%
Harmony Biosciences Holdings I
1.0%
Toro Co/The
1.0%
Textron Inc
1.0%
Emergent BioSolutions Inc
1.0%
Amdocs Ltd
1.0%
Danaher Corp
1.0%
Iridium Communications Inc
1.0%
Elevance Health Inc
1.0%
Grindr Inc
1.0%
Asset allocation
Stocks
99.5%
Cash
0.5%
Bonds
0.1%
By sector
Technology
25.7%
Consumer Cyclical
19.1%
Industrials
13.5%
Financial Services
13.1%
Communication
9.5%
Energy
9.3%
Healthcare
5.2%
Utilities
2.0%
Other
2.6%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
13.2%Moderate
Year-on-year price swings
Max drawdown
-35.7%Severe
Worst peak-to-trough loss
Sharpe (3Y)
0.87Decent risk-adjusted returns
Sortino (3Y)
1.29Good downside protection
Where to buy
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Seeks to generate long-term capital appreciation.
- Strategy
- Actively invests in U.S. companies from the largest 3,000 by market cap, focusing on those with insider buying and stock buybacks. Utilizes a proprietary multi-factor model to select and rank securities based on public equity float, free cash flow, financial leverage, and dividend yield.
- Inception date
- October 4, 2011
- Fund family
- AdvisorShares
Similar ETFs
Closest matches by profileWhat's next?
You've reviewed SURE. Save it to your watchlist to track it alongside the other funds you're weighing.
Data updated on 2026-06-19